diabetes — Lanton Law Blog

House Passes Insulin Bill

The U.S. House of Representatives has passed the Affordable Insulin Now Act seen here.

diabetes, healthcare, drug price, life sciences, Medicare Part D, reimbursementRon LantonApril 7, 2022Insulin, diabetes, Affordable Insulin Now Act, Centers for Medicare & Medicaid Services

What to Know about CURES 2.0

In November 2021, U.S. Reps. Fred Upton (R-MI) and Diana DeGette (D-CO) today introduced their bipartisan Cures 2.0 legislation. The bill which is aimed at helping patients of innovative companies within healthcare and life sciences can be viewed here.

Biosimilars, biologics, Congress, health system, healthcare, HealthIT, HHS, life sciencesRon LantonMarch 28, 2022CURES 2.0, 21st Century CURES Act, cancer, diabetes, ALS, Alzheimer’s, Advanced Research Projects Agency for Health, Clinical trials, CRO, laboratory

Prescription Digital Therapeutics (PDTs) Legislation Introduced

The Access to Prescription Digital Therapeutics Act of 2022 has been introduced by Reps. Mike Thompson (D-CA) and David McKinley (R-WV) and Sens. Jeanne Shaheen (D-NH) and Shelly Moore Capito (R-WV).

communications, FDA, health system, healthcare, HealthIT, HHSRon LantonMarch 10, 2022Prescription Digital Therapeutics, The Access to Prescription Digital Therapeutics Act of 2022, FDA, Opioids, mental health, diabetes

CURES 2.0 Biomedical Legislation Introduced Into Congress

U.S. Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) are back as they recently introduced their long anticipated and bipartisan Cures 2.0 legislation. The bill is discussed via Congresswoman DeGette’s press release.